PPRT 550

Drug Profile

PPRT 550

Alternative Names: Vitex agnus castus - PharmaPrint

Latest Information Update: 20 Feb 2008

Price : $50

At a glance

  • Originator PharmaPrint
  • Class Phytotherapies
  • Mechanism of Action
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Premenstrual syndrome

Most Recent Events

  • 09 Jan 2004 No development reported - Clinical-Phase-Unknown for Premenstrual syndrome in Germany (PO)
  • 26 Mar 2001 A study has been added to the Women's health therapeutic trials section
  • 14 Jul 2000 Investigation in Premenstrual syndrome in Germany (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top